Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month WAKEFIELD, MA – January 14, 2021 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a...